Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Revenue | 25.15 | 37.11 | 23.13 | 18.23 |
Total Revenue | 25.15 | 37.11 | 23.13 | 18.23 |
Costof Revenue Total | 9.53 | 28.63 | 16.68 | 11.81 |
Gross Profit | 15.61 | 8.48 | 6.45 | 6.42 |
Selling/ General/ Admin Expenses Total | 7.75 | 1.60 | 1.07 | -0.71 |
Depreciation/ Amortization | 1.83 | 1.82 | 1.63 | 1.81 |
Other Operating Expenses Total | 3.74 | 2.82 | 1.86 | 2.15 |
Total Operating Expense | 22.85 | 34.87 | 21.24 | 15.07 |
Operating Income | 2.29 | 2.23 | 1.88 | 3.17 |
Interest Inc( Exp) Net- Non- Op Total | -19.22 | -9.54 | -7.46 | -22.85 |
Other Net | 0.12 | -0.86 | -0.74 | -0.77 |
Net Income Before Taxes | 0.49 | 0.42 | 0.37 | 0.11 |
Provisionfor Income Taxes | 0.26 | 0.07 | 0.06 | 0.03 |
Net Income After Taxes | 0.23 | 0.35 | 0.31 | 0.08 |
Net Income Before Extra Items | 0.23 | 0.35 | 0.31 | 0.08 |
Net Income | 0.23 | 0.35 | 0.31 | 0.08 |
Income Availableto Com Excl Extra Ord | 0.23 | 0.35 | 0.31 | 0.08 |
Income Availableto Com Incl Extra Ord | 0.23 | 0.35 | 0.31 | 0.08 |
Diluted Net Income | 0.23 | 0.35 | 0.31 | 0.08 |
Diluted Weighted Average Shares | 0.97 | 0.94 | 0.48 | 0.48 |
Diluted EPS Excluding Extra Ord Items | 0.24 | 0.37 | 0.64 | 0.16 |
Diluted Normalized EPS | 0.24 | 0.37 | 0.68 | 0.16 |
Gain( Loss)on Saleof Assets | - | 0.00 | -0.23 | -0.03 |
Total Adjustmentsto Net Income | - | - | 0.00 | 0.00 |
Sampre Nutritions Dividend Sampre Nutritions Bonus Sampre Nutritions News Sampre Nutritions AGM Sampre Nutritions Rights Sampre Nutritions Splits Sampre Nutritions Board Meetings Sampre Nutritions Key Metrics Sampre Nutritions Shareholdings Sampre Nutritions Balance Sheet Sampre Nutritions Cashflow Sampre Nutritions Q1 Results Sampre Nutritions Q2 Results Sampre Nutritions Q3 Results Sampre Nutritions Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks